Ricardo Castrellon, MD
Payments from drug & device makers
Across 334 payments — averaging $147.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acell, Inc.$19K
- Integra Lifesciences Corporation$12K
- AbbVie$4K
- TELA Bio, Inc.$3K
- KCI USA, Inc.$2K
- Polynovo North America LLC$1K
- plus $7K from 40 others
What the payments were for
- Consulting fees$9,71520%
- Speaking & faculty fees$18,05037%
- Travel & lodging$6,52313%
- Food & beverage$14,39429%
- Education$1370%
- Other$4371%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$14,030
- NEURAGEN$3,360
- NATRELLE SALINE-FILLED BREAST IMPLANTS$2,996
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$2,218
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,838
- PRIMATRIX$1,435
- INTEGRA MESHED BILAYER WOUND MATRIX$1,260
- INTEGRA WOUND MATRIX (IWM)$1,260
- ADVANCED WOUND CARE$1,260
- CODMAN CERTAS$840
- SURGIMEND$840
- VAC VERAFLO$800
- PREVENA$800
- REVOLVE$473
- ACell$437
- Novosorb BTM$414
- PuraPly$360
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$305
- SMARTLOCK$299
- VISTASEAL$282
How this compares
$49,256 in reported general payments places this provider in the 90th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 16 | $152 |
Paid to pharmacies, not to this prescriber.
Other surgery in Miami
- Anthony GonzalezMiami$863K
- Jose MartinezMiami$186K
- Carlos BelloMiami$121K
- Emanuele Lo MenzoMiami$112K
- Jorge FlorinWinter Garden$2.2M
- Steven FagienBoca Raton$1.6M
- John MullinaxTampa$1.5M
- Amit TaggarTampa$1.4M
- Panagiotis SarantosGainesville$1.3M
- Keith KimCelebration$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.